Dawnrays Pharmaceutical (Holdings) Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dawnrays Pharmaceutical (Holdings) Ltd with three other
companies in this sector in Hong Kong:
Jacobson Pharma Corporation Ltd
sales of 1.08 billion Hong Kong Dollars [US$138.83 million]
of which 87%
was Generic drugs),
Lee's Pharmaceutical Holdings Ltd
(929.82 million Hong Kong Dollars [US$119.10 million]
of which 53%
was License-In Products), and
Golden Throat Holdings Group Co Ltd
(896.12 million Hong Kong Dollars [US$114.78 million]
During the year ended December of 2016, sales at
Dawnrays Pharmaceutical (Holdings) Ltd were HK$961.65 million (US$123.18 million).
decrease of 20.8%
versus 2015, when the company's sales were HK$1.21 billion.
Contributing to the drop in overall sales was the 35.4% decline
in Intermediates and Bulk Medicines, from HK$295.39 million to HK$190.83 million.
There were also decreases in sales in
Finished Drugs (down 16.1% to HK$770.82 million)